Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa

General

PSI has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.

Oxford welcomes global pandemic experts for focus on 100 Days Mission

General

Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.

CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

General

CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.

World-leading RECOVERY trial expands to investigate treatments for influenza

General

The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.

Researchers analyse UK COVID-19 Infection Survey data to tell the story of the virus' genomic evolution and spread

General

Research published today brings together for the first time the epidemiology and evolution of the SARS-CoV-2 virus in the UK during the first three years of the pandemic – including how variants emerged and spread.

Conference brings together clinical researchers to explore lessons from COVID-19 for global research collaboration

General

Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.

PSI seminar marks 25 years of Nipah virus

General

Over 60 researchers met this week to explore the latest research on deadly Nipah virus, including treatments, ethics and vaccines.

Global collaboration to develop next-generation COVID-19 and flu vaccines

General

The University of Oxford has launched a new global vaccine collaboration, backed by £8 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.

Professor Dame Sarah Gilbert awarded Freedom of the City of London

General

Professor Dame Sarah Gilbert, the Oxford Project Leader for the Oxford-AstraZeneca COVID-19 vaccine and Pandemic Sciences Institute researcher, has received the Freedom of the City of London in recognition of her outstanding achievements in, and contribution to, science and public health.

Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

General

The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.

Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched

General

A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.

CEPI and University of Oxford to accelerate vaccine development against Disease X

General

The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.

New partnership to enhance global surveillance of pandemic threats

General

PSI and the WHO Hub for Pandemic and Epidemic Intelligence will collaborate to improve the detection and tracking of infectious diseases.

Preparing for the next pandemic together

General

PSI Director Professor Sir Peter Horby explains how relationships across scientific disciplines, sectors and global regions are key to preventing and preparing for future pandemics.

PSI hosts Oxford conference to prepare for future of pandemics

General

Representatives from academia, industry, policy and civil society are gathering in Oxford next week to discuss the latest scientific advances that are ensuring the world is better prepared for future pandemics.

PSI Director tells MPs why investment in pandemic research is critical

General

PSI Director Professor Sir Peter Horby today gave evidence at the House of Commons’ Science, Innovation and Technology Select Committee Inquiry on Emerging Diseases and Learnings from COVID-19.

Professor Sir Andrew Pollard reveals unique insights into the world of science in a new podcast

General

Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.

Call for abstracts: International Pandemic Sciences Conference

General

Abstract submission for the International Pandemic Sciences Conference 2023 - Making the Exceptional Routine has been extended to Friday 28 April 2023.

£12 million investment for Future Vaccines Manufacturing Hub

General

A new Future Vaccines Manufacturing Hub – co-led by University of Oxford and University College London – aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.

Sarah Gilbert receives King Faisal Prize for Medicine

General

Professor Dame Sarah Gilbert has been awarded the prestigious King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.

Load More